» Articles » PMID: 27013813

Prevalence of Beta-Hemolytic Streptococci Groups A, C, and G in Patients with Acute Pharyngitis

Overview
Specialty Pathology
Date 2016 Mar 26
PMID 27013813
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Group A beta-hemolytic streptococci (GAS) is the most frequently isolated pathogen in acute pharyngitis. However, the role of Group C (GCS) and Group G (GGS) streptococci in disease burden is under recognized. The present study is carried out to find out the prevalence of acute pharyngitis caused by the different serogroups of streptococci and antibiotic susceptibility pattern of these streptococcal isolates.

Study And Design: A cross sectional study.

Materials And Methods: A total of 218 throat swabs from patients with acute pharyngitis and 82 from healthy controls were collected and processed as per standard protocol. Samples were inoculated on blood agar and Streptococcus selective agar. Isolates were identified by the conventional method and serogrouped by latex agglutination test using Remel Streptex kit.

Results: Beta-hemolytic streptococci (BHS) were isolated from 34 (15.59%) of pharyngitis patients and 11 (13.41%) of the healthy carrier. Among pharyngitis, GAS was isolated from 20 (9.17%), GCS 7 (3.21%), and GGS 7 (3.21%) patients. Carriage rate of GAS was 6 (7.31%) and GCS, 5 (6.09%). Vancomycin (100%), amoxyclavulanic acid (90%), levofloxacin (85%), and cephotaxime (80%) were found to be most effective antibiotics. Comparatively, higher drug resistance was observed among GCS and GGS to all the drugs used in the study except for levofloxacin.

Conclusions: Although rate of pharyngitis associated with GCS and GGS is marginally lower than GAS, their carriage rate among healthy and relative higher drug resistance emphasizes the need for periodic surveillance of infection by the different serogroups of BHS.

Citing Articles

Associated Bacterial Coinfections in COVID-19-Positive Patients.

Boia E, Hut A, Roi A, Luca R, Munteanu I, Roi C Medicina (Kaunas). 2023; 59(10).

PMID: 37893576 PMC: 10607966. DOI: 10.3390/medicina59101858.


Pathogenicity Factors in Group C and G Streptococci.

Turner C, Bubba L, Efstratiou A Microbiol Spectr. 2019; 7(3).

PMID: 31111818 PMC: 11026075. DOI: 10.1128/microbiolspec.GPP3-0020-2018.


Clinical Screening Tools to Diagnose Group A Streptococcal Pharyngotonsillitis in Primary Care Clinics to Improve Prescribing Habits.

Muthanna A, Salim H, Hamat R, Shamsuddin N, Zakariah S Malays J Med Sci. 2019; 25(6):6-21.

PMID: 30914875 PMC: 6422577. DOI: 10.21315/mjms2018.25.6.2.


Invasive group G streptococcal infection in a paediatric patient.

Bhavsar S, Shust G BMJ Case Rep. 2016; 2016.

PMID: 27993825 PMC: 5174835. DOI: 10.1136/bcr-2016-217790.

References
1.
Bramhachari P, Kaul S, McMillan D, Shaila M, Karmarkar M, Sriprakash K . Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children. J Med Microbiol. 2009; 59(Pt 2):220-223. DOI: 10.1099/jmm.0.015644-0. View

2.
Menon T, Lloyd C, Jacob S . Should bacitracin sensitivity be used in the presumptive identification of group A streptococci?. Indian J Med Microbiol. 2005; 23(4):275. View

3.
De Melo M, Figueiredo A, Ferreira-Carvalho B . Antimicrobial susceptibility patterns and genomic diversity in strains of Streptococcus pyogenes isolated in 1978-1997 in different Brazilian cities. J Med Microbiol. 2003; 52(Pt 3):251-258. DOI: 10.1099/jmm.0.04938-0. View

4.
Al-Charrakh A, Al-Khafaji J, Al-Rubaye R . Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis. N Am J Med Sci. 2012; 3(3):129-36. PMC: 3336899. DOI: 10.4297/najms.2011.3129. View

5.
Jing H, Ning B, Hao H, Zheng Y, Chang D, Jiang W . Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol. 2006; 55(Pt 8):1101-1107. DOI: 10.1099/jmm.0.46243-0. View